A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

Six-month clinical data from 40 patients highlights safety, effective decongestion, stable renal function, and reduced ...

Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...

Following an acute heart attack, pathological remodeling processes occur in the heart. One consequence is so-called left ...

Results from the first randomised trial evaluating microRNA inhibition in heart failure were presented today at Heart Failure 2026.

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Heart disease is still the top cause of death in the US, but the types of heart disease killing people are changing, a new analysis has found. While deaths from acute conditions such as heart attacks ...